Dicyclomine Hydrochloride Tablet
Product Images NDC 67296-2142

This product is Dicyclomine Hydrochloride tablets, each containing 20 mg of the active ingredient. The dosage information can be found in the package insert. It should be stored between 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The tablets should be protected from light and dispensed in a well-closed container with a child-resistant closure. The manufacturer is Rubicon Research Ltd. in India, and they are distributed by Advagen Pharma Ltd. in the USA. More information is available at the provided website link.*

This text provides information about Dicyclomine Hydrochloride tablets with a dosage of 20mg. It includes instructions for storage, dosage, and administration. The tablets are cautioned to be kept away from children and dispensed in a child-resistant container. The package insert can be accessed online. The tablets are distributed by Advagen Pharma in the USA and manufactured by Rubicon Research in India. The manufacturing license number is KD-682 Rev.04, 11/24.*

This is a description of a medication containing 20 mg of Dicyclomine Hydrochloride, USP. The text includes dosage instructions, storage guidance, pharmacist directions, a warning to keep out of reach of children, and detailed information about the manufacturer and distributor. It is available in tablet form and each package contains 30 tablets. The manufacturer is Rubicon Research Private Limited located in India. The distributor is Advagen Pharma Limited based in the USA.*

This is a description of Dicyclomine Hydrochloride tablets, each containing 20 mg of the active ingredient. The dosage and administration details are provided on the package insert. The tablets should be stored between 20°C to 25°C with excursions permitted between 15°C to 30°C. It is vital to protect the tablets from light and keep them out of reach of children. The tablets are distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. The packaging contains 500 tablets and is meant for prescription use only.*

This text is a label for Dicyclomine Hydrochloride tablets, each containing 40 mg of the active ingredient. It provides information on dosage, storage conditions, and a warning to keep the medication out of reach of children. The label includes contact information for the distributor and manufacturer, as well as a link to the package insert for more detailed information. The tablets are available in a package of 1000 tablets and are for prescription use only.*

This is a description for Dicyclomine Hydrochloride tablets. Each tablet contains 40 mg of Dicyclomine Hydrochloride, USP. It is advised to refer to the package insert for dosage and administration information. The tablets should be stored at 20° to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F) to avoid light exposure. Pharmacists should dispense the tablets in a well-closed container with a child-resistant closure. The product should be kept out of reach of children. The tablets are distributed by Advagen Pharma Limited in Plainsboro, NJ, USA, and manufactured by Rubicon Research Private Limited in India.*

This text appears to be describing a medication called Dicyclomine Hydrochloride, with each tablet containing 40 mg of the active ingredient. The medication is distributed by Advagen Pharma Ltd. The manufacturer is Rubicon Research Ltd. The dosage information can be found in the package insert. The storage instructions recommend keeping the tablets between 20°C to 25°C. The pharmacist is advised to dispense the medication in a well-closed container with child-resistant closure. A warning is given to keep the tablets out of reach of children. Additional details may be available on the package insert, which is 43mm x 20mm in size. The website provided is advagenpharma.com.*

This text provides information on Dicyclomine Hydrochloride tablets manufactured by Advagen Pharma Ltd. Each tablet contains 4 mg of the active ingredient. The dosage information is available in the package insert. It's advisable to store the tablets between 20°C to 25°C and protect them from light. The text also includes a warning to keep the tablets out of reach of children and guidance for pharmacists to dispense in a well-closed container with a child-resistant closure. The product is distributed in a pack of 30 tablets and is prescription-only.*

This text provides information about a tablet containing 40 mg of Dicyclomine Hydrochloride, USP manufactured by Rubicon Research Ltd. The dosage and administration details are found in the package insert, along with storage recommendations at temperatures between 20° to 25°C. It emphasizes protecting the tablets from light, keeping them out of reach of children, and dispensing them in a well-closed container with a child-resistant closure. More details can be found on the manufacturer's website at advagenpharma.com.*